MIDD beats Q1 EPS/revenue estimates despite sales dip; guidance lifts. Stock up 4.6%.
Novo Nordisk & Eli Lilly shares surge on oral weight-loss pills, expanding market & boosting valuations.
Oil futures volume spikes pre-report, raising insider trading concerns. Prices tumbled 7% post-news.
BKV's revenue soared 449% beating estimates, but FCF remains weak & volatile. Buy signal?
IBP misses revenue & EPS targets; stock dips 10.6%. Long-term growth strong, but recent slowdowns raise concerns.
PAYO beats Q1 estimates with 6.1% revenue growth & 2.5% stock jump. Valuation & long-term trends matter.
DoorDash stock jumps 12% on strong earnings beat & record signups, despite revenue miss. GOV beats.
Sponsored
Must Read